Drugs

, Volume 66, Issue 9, pp 1253–1261 | Cite as

Probiotics for Prevention of Recurrent Urinary Tract Infections in Women

A Review of the Evidence from Microbiological and Clinical Studies
  • Matthew E. Falagas
  • Gregoria I. Betsi
  • Theodoros Tokas
  • Stavros Athanasiou
Review Article

Abstract

Recurrent urinary tract infections (UTIs) afflict a great number of women around the world. The use of probiotics, especially lactobacilli, has been considered for the prevention of UTIs. Since lactobacilli dominate the urogenital flora of healthy premenopausal women, it has been suggested that restoration of the urogenital flora, which is dominated by uropathogens, with lactobacilli may protect against UTIs. This review is based on a search of PubMed for relevant articles. Many in vitro studies, animal experiments, microbiological studies in healthy women, and clinical trials in women with UTIs have been carried out to assess the effectiveness and safety of probiotics for prophylaxis against uropathogens. Most of them had encouraging findings for some specific strains of lactobacilli. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 (previously called L. fermentum RC-14) seemed to be the most effective among the studied lactobacilli for the prevention of UTIs. L. casei shirota and L. crispatus CTV-05 have also shown efficacy in some studies. L. rhamnosus GG did not appear to be quite as effective in the prevention of UTIs. The evidence from the available studies suggests that probiotics can be beneficial for preventing recurrent UTIs in women; they also have a good safety profile. However, further research is needed to confirm these results before the widespread use of probiotics for this indication can be recommended.

Keywords

Lactobacillus Bacterial Vaginosis Recurrent Urinary Tract Infection Vaginal Flora Vaginal Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors received no funding for the preparation of this manuscript and have no potential conflicts of interest directly relevant to its contents.

References

  1. 1.
    Foxman B, Barlow R, D’Arcy H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10: 509–15PubMedCrossRefGoogle Scholar
  2. 2.
    Reid G, Jass J, Sebulsky T, et al. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16: 658–72PubMedCrossRefGoogle Scholar
  3. 3.
    Senok A, Ismaeel A, Botta G. Probiotics: facts and myths. Clin Microbiol Infect Dis 2005; 11(12): 958–66CrossRefGoogle Scholar
  4. 4.
    De Vrese M, Schrezenmeir J. Probiotics and non-intestinal infectious conditions. Br J Nutr 2002; 88: S59–66CrossRefGoogle Scholar
  5. 5.
    Antonio M, Hawes S, Hillier S. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonised by these species. J Infect Dis 1999; 180: 1950–6PubMedCrossRefGoogle Scholar
  6. 6.
    Zhou X, Bent SJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004; 150: 2565–73PubMedCrossRefGoogle Scholar
  7. 7.
    Burton J, Cardieux P, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003; 69: 97–101PubMedCrossRefGoogle Scholar
  8. 8.
    Bruce AW, Chadwick P, Hassan A, et al. Recurrent urethritis in women. CMAJ 1973 Apr; 108(8): 973–6Google Scholar
  9. 9.
    Stamm W, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28: 723–5PubMedCrossRefGoogle Scholar
  10. 10.
    Keane F, Ison C, Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 1997; 8: 489–94PubMedCrossRefGoogle Scholar
  11. 11.
    Reid G, Sobel J. Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev Infect Dis 1987; 9: 470–87PubMedCrossRefGoogle Scholar
  12. 12.
    Hawthorn LA, Reid G. Exclusion of uropathogen adhesion to polymer surfaces by Lactobacillus acidophilus. J Biomed Mater Res 1990; 24(1): 39–46PubMedCrossRefGoogle Scholar
  13. 13.
    Velraeds MM, van de Belt-Gritter B, van der Mei HC, et al. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 1998; 47(12): 1081–5PubMedCrossRefGoogle Scholar
  14. 14.
    Heineman C, van Hylckama Vlieg JE. Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibit adhesion of Enterococcus faecalis 1131. FEMS Microbiol Lett 2000; 190(1): 177–80CrossRefGoogle Scholar
  15. 15.
    Osset J, Bartolome RM, Garcia E, et al. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001; 183(3): 485–91PubMedCrossRefGoogle Scholar
  16. 16.
    Reid G, Cook RL, Bruce AW. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol 1987; 138(2): 330–5PubMedGoogle Scholar
  17. 17.
    McGroaty JA, Reid G. Detection of lactobacillus substance that inhibits Escherichia Coli. Can J Microbiol 1998; 34(8): 974–8CrossRefGoogle Scholar
  18. 18.
    Reid G, Chan RC, Bruce AW, et al. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infect Immun 1985; 49(2): 320–4PubMedGoogle Scholar
  19. 19.
    Herthelius M, Gorbach SL. Elimination of vaginal colonisation with Escherichia coli by administration of indigenous flora. Infect Immun 1989; 57(8): 2447–51PubMedGoogle Scholar
  20. 20.
    Silva de Ruiz C, Lopez de Bocanera ME, Nader de Macias ME, et al. Effect of lactobacilli and antibiotics on E. coli urinary infections in mice. Biol Pharm Bull 1996; 19(1): 88–93Google Scholar
  21. 21.
    Asahara T, Nomoto K, Watanuki M, et al. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 2001 Jun; 45(6): 1751–60PubMedCrossRefGoogle Scholar
  22. 22.
    Patton DL, Cosgrove Sweeney YT, Antonio MA, et al. Lactobacillus crispatus capsules: single-use safety study in the Macaca nemestrina model. Sex Transm Dis 2003 Jul; 30(7): 568–70PubMedCrossRefGoogle Scholar
  23. 23.
    Colodner R, Edelstein H, Chazan B, et al. Vaginal colonisation by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J 2003; 5(11): 767–9PubMedGoogle Scholar
  24. 24.
    Cardieux P, Burton J, Gardiner G, et al. Lactobacillus strains and vaginal ecology. JAMA 2002; 287: 1940–1CrossRefGoogle Scholar
  25. 25.
    Reid G, Beuerman D, Heinemann C, et al. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001; 32: 37–41PubMedCrossRefGoogle Scholar
  26. 26.
    Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003; 35: 131–4Google Scholar
  27. 27.
    Morelli L, Zonenenschain D, Del Piano M, et al. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 2004; 38: S107–10PubMedCrossRefGoogle Scholar
  28. 28.
    Hoesl CE, Altwein JE. The probiotic approach: an alternative treatment option in urology. Eur Urol 2005; 47: 288–96PubMedCrossRefGoogle Scholar
  29. 29.
    Newman D. Treatment of cystitis by intravesical injections of lactic bacillus cultures. Lancet 1915; II: 330CrossRefGoogle Scholar
  30. 30.
    Hagberg L, Bruce AW, Reid G, et al. Colonisation of the urinary tract with live bacteria from the normal fecal and urethral flora in patients with recurrent symptomatic urinary tract infections. In: Kass EH, Svanborg Eden C, editors. Host-parasite interactions in urinary tract infections. Chicago (IL): University of Chicago Press, 1989: 194–7Google Scholar
  31. 31.
    Bruce AW, Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol 1988; 34: 339–43PubMedCrossRefGoogle Scholar
  32. 32.
    Reid G, Bruce AW, Taylor M. Influence of 3-day antimicrobial therapy and Lactobacillus suppositories on recurrence of urinary tract infection. Clin Ther 1992; 14: 11–6PubMedGoogle Scholar
  33. 33.
    Reid G, Millsap K, Bruce A. Implantation of Lactobacillus casei var rhamnosus into vagina. Lancet 1994; 344: 1229PubMedCrossRefGoogle Scholar
  34. 34.
    Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995; 23: 32–45Google Scholar
  35. 35.
    Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent urinary tract infection in women. Scand J Prim Health Care 1994; 12: 239–43PubMedCrossRefGoogle Scholar
  36. 36.
    Tomoda T, Nakano Y, Kageyama T. Intestinal Candida overgrowth and Candida infection in patients with leukemia: effect of Bifidobacterium administration. Bifidobacteria Microflora 1988; 7: 71–4Google Scholar
  37. 37.
    Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001; 322: 1–5CrossRefGoogle Scholar
  38. 38.
    Kontiokari T, Laitinen J, Jarvi L, et al. Dietary factors protecting women from urinary tract infection. J Clin Nutr 2003; 77: 600–4Google Scholar
  39. 39.
    Reid G, Bruce A, Fraser N, et al. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001; 30: 49–52PubMedCrossRefGoogle Scholar
  40. 40.
    Husni R, Gordon S, Washington J, et al. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 1997; 25: 1048–55PubMedCrossRefGoogle Scholar
  41. 41.
    Borriello S, Hammes W, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36: 775–80PubMedCrossRefGoogle Scholar
  42. 42.
    Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst Pasteur 1994; 92: 45–67Google Scholar
  43. 43.
    Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999; 28: 1159–60CrossRefGoogle Scholar
  44. 44.
    Mackay A, Taylor M, Kibbler C, et al. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999; 5: 290–2PubMedCrossRefGoogle Scholar
  45. 45.
    Adams M, Marteau P. On the safety of lactic acid bacteria from food. Int J Food Microbiol 1995; 27: 263–4PubMedCrossRefGoogle Scholar
  46. 46.
    Andreu A. Lactobacillus as a probiotic for preventing urogenital infections. Rev Med Microbiol 2004 Jan; 15(1): 1–6CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  • Matthew E. Falagas
    • 1
    • 2
  • Gregoria I. Betsi
    • 1
  • Theodoros Tokas
    • 1
  • Stavros Athanasiou
    • 3
  1. 1.Alfa Institute of Biomedical Sciences (AIBS)AthensGreece
  2. 2.Department of MedicineTufts University School of MedicineBostonUSA
  3. 3.First Department of Obstetrics and GynecologyAthens University School of MedicineGreece

Personalised recommendations